Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 13, 2003 - Issue 9
Submit an article Journal homepage
224
Views
31
CrossRef citations to date
0
Altmetric
Review

Inhalation drug delivery devices and emerging technologies

Hak-Kim Chan Faculty of Pharmacy, A15, University of Sydney, NSW 2006, Australia. [email protected]
Pages 1333-1343 | Published online: 02 Mar 2005

Bibliography

  • BISGAARD HS, O'CALLAGHAN C, SMALDONE GC (Eds): Drug Delivery to the Lung. Marcel Dekker, Inc., New York, USA (2002).
  • MOREN F, DOLOVICH MB, NEWHOUSE MT et al. (Eds): Aerosols in Medicine: Principles, Diagnosis and Therapy Elsevier Science Publishing, Amsterdam, The Netherlands (1993).
  • BARNES PJ, DRAZEN JM, RENNARD S et al. (Eds): Asthma and COPD: Basic Mechanisms and Clinical Management. Academic Press, London, UK (2002).
  • CHUNG KF, BARNES PJ: Mediator antagonists. In: Asthma, and COPD: Basic Mechanisms and Clinical Management. Barnes PJ, Drazen JM, Rennard S et al (Eds), Academic Press, London, UK (2002):565–571.
  • SMITH AL: Inhaled antibiotic therapy: what drug? what dose? what regimen? what formulation?' Cystic Fibrosis (2002) 1:S189–S193.
  • CIPOLLA DC, CALRK AR, CHAN H-K et al.: Assessment of aerosol delivery systems for recombinant human deoxyribonuclease. STP Pharma Sciences (1994) 4:50–62.
  • MATHER LE, WOODHOUSE A, WARD ME et al: Pulmonary administration of aerosolized fentanyl: pharmacokinetic analysis of a systemic delivery. Br. J. Clin. Pharmacol (1998) 46:37–43.
  • DERSHWITZ M, WALSH JL, MORISHIGE RJ et al.: Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers. Anesthesiology(2000) 93:619–628.
  • WARD ME, WOODHOUSE A, MATHER LE et al.: Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system. Clin. Pharmacol Ther. (1997) 62:596–609.
  • SKYLERJ, CEFALU W, KOURIDES let al: Efficacy of inhaled human insulin in Type 1 diabetes mellitus: a randomised proof-of-concept study. Lancet (2001) 357:331–335.
  • CEFALU W, SKYLER J, KOURIDES I et al.: Insulin human insulin treatment in patients with Type 2 diabetes mellitus. Ann. Intern. Med. (2001) 134:203–207.
  • PERERA A, KAPITZA C, NOSEK L et al.: Absorption and metabolic effect of inhaled insulin. Diabetes Care (2002) 25:2276–2281.
  • CLARK AR: Medical aerosol inhalers: past, present and future. Aerosol Sci. Tech. (1995) 22:374–381.
  • MOHSEN NM: pMDI aerosol momentum manipulation and biotargeted delivery. In: Respiratory Drug Delivery VIII Dalby RN, Byron PR, Peart J, Farr SJ (Eds), Davis Horwood International Publishing, Godalming/Surrey, USA (2002):593–597.
  • VERVAET C, BYRON P: Drug-surfactant-propellant interactions in HFA-formulations. Int. J. Pharm. (1999) 186:13–30.
  • KELLER M: Innovations and perspectives of metered-dose inhalers in pulmonary drug delivery. Int. .1. Pharm. (1999) 186:81–90.
  • MEAKIN BJ, LEWIS DA, GANDERTON D et al.: Countering challenges posed by mimicry of DFD performance using LTA systems. In: Respiratory Drug Delivery VII Dalby RN, Byron PR, Farr SJ, Peart J (Eds), Serentec Press, Raleigh, NC, USA (2000):99–107.
  • STFELY JS, BROWN B, HAMMERBECK DM et al.: Equipping the MDI for the 21st century by expanding its formulation options. In: Respiratory Drug Delivery VIII Dalby RN, Byron PR, Peart J, Farr SJ (Eds), Davis Horwood International Publishing, Godalming/Surrey, USA (2002)207–213.
  • CHAN H-K, GONDA I: Development of systematic theory of suspension inhalation aerosols. II. Aggregates of monodisperse particles nebulised in polydisperse droplets. hat. Pharm. (1988) 41:147–157.
  • NEWHOUSE MT, HIRST PH, DUDDU SP et al: Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers. Chest (2003) 124:360–366.
  • ANDERSON SD, BRANNAN JD, CHAN H-K: Use of aerosols for bronchial provocation testing in the laboratory: where we have been and where we are going. Aerosol Med. (2002) 15:313–324.
  • DENYER J, PAVIA D, ZIERENBERG B: New liquid drug aerosol devices for inhalation therapy. Lim Respir. Rev (2000) 10:187–191.
  • KASTELIK JA, WRIGHT GA, AZIZ I et al.: A widely available method for the assessment of aerosol delivery in cystic fibrosis. Pulmon. Pharmacol Ther. (2002) 15:513–519.
  • SOMMERER K, BRAND MP, MULLINGER B et al.: A strategy to optimize peripheral lung deposition in patients with emphysema. In: Respiratory Drug Delivery VIII Dalby RN, Byron PR, Peart J, Farr SJ (Eds), Davis Horwood International Publishing, Godalming/ Surrey, USA (2002):475–478.
  • YOSHIYAMA Y, YAZAKI T, ARAI M et al.: The nebulization of budesonide suspensions by a newly developed mesh nebulizer. In: Respiratory Drug Delivery VIII Dalby RN, Byron PR, Peart J, Farr SJ (Eds), Davis Horwood International Publishing, Godalming/Surrey, USA (2002):487–489.
  • CIPOLLA D, FARR S, FIORE M et al: AREx: synthesis of technologies to provide therapeutic benefits via pulmonary drug delivery. Polymer Preprints (1999) 40:326–327.
  • SIMON M, GOPALAKRISHNAN V: AeroDose'm inhaler - feasibility studies with the aerosol generator. In: Respiratory Drug Delivery VII Dalby RN, Byron PR, Farr SJ, Peart J (Eds), Serentec Press, Raleigh, NC, USA (2000):311–314.
  • WISSINK JM, VAN RIJN CJM: Smart micromachined nozzles for monodisperse aerosol generation using low pressure Rayleigh break-up. In: Respiratory Drug Delivery VIII Dalby RN, Byron PR, Peart J, Farr SJ (Eds), Davis Horwood International Publishing, Godalming/ Surrey, USA (2002):509–512.
  • SMART J, BERG E, BERBRINK 0 et al: TouchSprairm technology: comparison of the droplet size measured with cascade impaction and laser diffraction. In: Respiratory Drug Delivery VIII Dalby RN, Byron PR, Peart J, Farr SJ (Eds), Davis Horwood International Publishing, Godalming/Surrey, USA (2002):525–528.
  • GOODALL S, CHEW N, CHAN K et al.: Aerosolisation of protein solutions using thermal ink jet technology. J. Aerosol Med. (2002)15:351–357.
  • ZIMLICH W, DING J, BUSICK D etal.: Development of multiple clinical and commercial applications using Mystic' inhalation delivery technologies. In: Rey:notary Drug Delivery Viii Dalby RN, Byron PR, PeartJ, Farr SJ (Eds), Davis Horwood International Publishing, Godalming/Surrey, USA (2002):363–366.
  • SPALLEK MW HOCHRAINER D, WACHTEL H: Optimising nozzles for soft mist inhalers. In: Re:yr:rotary Drug Delivery VIII Dalby RN, Byron PR, Peart J, Farr SJ (Eds), Davis Horwood International Publishing, Godalming/Surrey, USA (2002):375–378.
  • VILLAX p, BRITO V, STECKEL H: Development and performance of a new simple dry powder inhaler operating at low airflow rates. In: Respiratory Drug Del/very VIH. Dalby RN, Byron PR, Peart J, Farr SJ (Eds), Davis Horwood International Publishing, Godalming/Surrey, USA (2002):459–462.
  • LIGOTKE NW: Develoment and characterization of a dry powder inhaler. In: Respiratory Drug Delivery V/H. Dalby RN, Byron PR, Peart J, Farr SJ (Eds), Davis Horwood International Publishing, Godalming/Surrey, USA (2002):419–422.
  • CLARK AR, SHIRE SJ: In: Protein Formulation and Delivery McNally EJ (Ed.) Marcel Dekker, Inc., New York, USA (2000):214–216.
  • LUCAS P, CLARKE MJ, ANDERSON M et al.: The role of fine particle excipients in pharmaceutical dry powder aerosols. In: Respiratory Drug Delivery VI Dalby RN, Byron PR, Farr SJ (Eds), Interpharm Press, Ii, USA (1996):243–250.
  • KELLER M, MULLER-WALZ R, GILCHRIST P et al.: Effect of storage on the in vitro performance of formoterol-fumarate powder blends in the SkyePharma MDPI. In: Respiratory Drug Delivery VII Dalby RN, Byron PR, Farr SJ, Peart J (Eds), Serentec Press, Raleigh, NC, USA (2000):511–514.
  • LUCAS P, ANDERSON K, POTTER UJ et al.: Enhancement of small particle size drug powder aerosol formulations using an ultra low density additive. Pharm. Res. (1999) 16:1643–1647.
  • FULTS KA, MILLER IF, HICKEY AJ: Effect of particle morphology on emitted dose of fatty acid-treated disodium cromoglycate powder aerosols. Pharm. Dev Technol (1997) 2:67–79.
  • BYRON PR, PEART J, STANIFORTH JN: Aerosol electrostatics I: properties of fine powders before and after aerosolization by dry powder inhalers. Pharm. Res. (1997) 14:698–705.
  • CHAN H-K, CLARK A, GONDA I et al: Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery. Pharm. Res. (1997) 14:431–437.
  • YAMASHITA C, NISHIBAYASHI T, AKASHI S et al.: A novel formulation of dry powder for inhalation of peptides and proteins. In: Respiratory Drug Delivery VI Dalby RN, Byron PR, Farr SJ (Eds), Interpharm Press, Buffalo Grove, IL, USA (1996): 483–485.
  • CHEW NYK, CHAN H-K: Effect of amino acids on the dispersion of spray dried cromoglycate powders as aerosol. In: Respiratory Drug Delivery VIII Dalby RN, Byron PR, Peart J, Farr SJ (Eds), Davis Horwood International Publishing, Godalming/Surrey, USA (2002):619–622. 1341
  • MAA Y-F, NGUYEN P-A, SWEENEY T et al.: Protein inhalation powders: spray drying versus spray freeze drying. Pharm. Res. (1999) 16:249–254.
  • EDWARDS DA, HANES J, CAPONETTI G et al.: Large porous particles for pulmonary drug delivery. Science (1997) 276:1868–1871.
  • BOT AI, TARARA TE, SMITH DJ et al: Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract. Pharm. Res. (2000) 17:275–283.
  • CHEW NYK, CHAN H-K: Use of solid corrugated particles to enhance powder aerosol performance. Pharm. Res. (2001) 18:1570–1577.
  • DUDDU SP, SISK SA, WALTER YH et al.:Improved lung delivery from a passive dry powder inhaler using an engineered PulmoSphere powder. Pharm. Res. (2002) 19:689–695.
  • OSTRANDER KD, HOVEY DC, KNAPP DA et al.: Potential delivery advantages of spray-dried Nanocrystals' colloidal budesonide with the Clickhaler°. In: Respiratory Drug Delivery VII Dalby RN, Byron PR, Farr SJ, PeartJ (Eds), Serentec Press, Raleigh, NC, USA (2000):447–449.
  • MASTERS K: Spray Drying Handbook (3rd edn). Halsted Press, New York, USA (1979).
  • WATANABE W, AHONEN P, KAUPPINEN E et al.: Novel method for the synthesis of inhalable multicomponent drug powders with controlled morphology and size. In: Respiratory Drug Delivery VIII Dalby RN, Byron PR, Peart J, Farr SJ (Eds), Davis Horwood International Publishing, Godalming/ Surrey, USA (2002):795–797.
  • MAA YF, NGUYEN P-A, SWEENEY T et al.: Protein inhalation powders: spray drying versus spray freeze drying. Pharm. Res. (1999) 16:249–254.
  • CHEN JF, WANG YH, GUO F et al.: Synthesis of nanoparticles with nanotechnology: high-gravity reaction precipitation. Ind. Eng. Chem. Res. (2000) 39:948–954.
  • YORK P, HANNA M: Particle engineering by supercritical fluid technologies for powder inhalation drug delivery. In: Proceedings of Reipiratory Drug Delivery VI Dalby RN, Byron PR, Farr SJ (Eds), Interpharm Press, Buffalo Grove, IL, USA (1996):231–239.
  • SIEVERS RA, SELLERS T, CLARK GS, VILLA JA, MIOSKOWSKI B, CARPENTER J: Supercritical fluid carbon dioxide technologies for fine particle formation for pulmonary drug delivery. 219th ACS National Meeting, San Francisco, CA, USA (March 2000):MSDI–173.
  • BUSTAMI RT, CHAN H-K, DEHGHANI F et al.: Recent application of supercritical fluid technology to pharmaceutical powder systems, Kona, powder and particle (2001) 19:57–70.
  • BUSTAMI RT, CHAN H-K, DEHGHANI F et al: Generation of micro-particles of proteins for aerosol delivery using high pressure modified carbon dioxide. Pharm. Res. (2000) 17:1360–1366.

Websites

  • http://www.nektar.com/content/pipeline Pipeline overview - Nektar Therapeutics.
  • http://www.lungcanceronline.org/ treatment-agents/R/resmycin.html Lung Cancer Online: Treatment agents and regimens: Resmycin (inhaled doxorubicin).
  • http://www.alkermes.com/products/ pipeline.html Product pipeline - Alkermes.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.